Ampio raises $12.732 million through private placement of common stock

Ampio Pharmaceuticals, Inc. (OTC Bulletin Board: AMPE)("Ampio") announced today the successful completion of a private placement from which Ampio received gross proceeds of $12.732 million.  Fordham Financial Management, Inc., New York, New York, acted as the placement agent in the offering.  Ampio sold 5,092,880 of its shares of common stock in the placement, with no investor warrants or convertible securities attached. The proceeds of the placement will be used to facilitate and further the completion and analysis of data for ongoing and multiple future clinical trials, and for general corporate purposes. "This financing exceeded our expectations and was oversubscribed. We look forward to applying the majority of these funds to development of our lead drug candidates and medical device," said Don Wingerter, CEO of Ampio.

Ampio also announced that it will file today a resale registration statement with the United States Securities and Exchange Commission (the “SEC”).  The registration statement registers for resale the 1,281,852 shares of Ampio common stock issued on February 28, 2011 following conversion of all outstanding Ampio convertible debentures, as well as 4,760,380 of the shares of common stock sold in the placement. The selling securityholders are under no obligation to sell the common stock on effectiveness of the registration statement.